Review
The blood-brain barrier and the inflammatory response

https://doi.org/10.1016/S1357-4310(97)01077-0Get rights and content

The environment of the brain is controlled by a sophisticated endothelial barrier that prevents the free entry of solutes from the blood. It is commonly assumed that this blood-brain barrier (BBB) also prevents the entry of leukocytes into the central nervous system. However, recent evidence in animal models shows that this is not the case, and leukocytes can cross an intact BBB during health and disease. Indeed, in many neurological diseases, including Alzheimer's disease, prion diseases and AIDS-related dementia, leukocytes enter the brain parenchyma without concomitant BBB breakdown. Current research is concentrating on factors that control the integrity of the BBB and the mechanisms that leukocytes use to enter the brain.

References (40)

  • OppenheimerR.W.

    Cell death during development of the nervous system

    Annu. Rev. Neurosci.

    (1991)
  • PerryV.H.

    Glial cell development

  • SaundersN.R. et al.

    The importance of blood-brain barriers in fetuses and embryos

    Trends Neurosci

    (1991)
  • LingE.A. et al.

    The origin and nature of ramified and amoeboid microglia: a historical review and current concepts

    Glia

    (1993)
  • MickeyW.F. et al.

    Bone marrow derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimera

    J Neuropathol. Exp. Neurol.

    (1992)
  • BellM.D.

    Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammogen or during acute neuronal degeneration

    J. Neurocytol.

    (1995)
  • GreenwoodJ. et al.

    The blood-retinal barrier in experimental autoimmune uveoretinitis

    Lab. Invest.

    (1994)
  • PowerC. et al.

    HIV-1 associated dementia: clinical features and pathogenesis

    Can. J. Neurol Sci.

    (1995)
  • WedmoreC.V. et al.

    Control of vascular permeability by polymorphonuclear leukocytes in inflammation

    Nature

    (1981)
  • AnderssonP-B. et al.

    Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system

    J. Exp. Med.

    (1992)
  • Cited by (130)

    • Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression

      2015, Nanomedicine: Nanotechnology, Biology, and Medicine
      Citation Excerpt :

      After incubation, the suspension in the lower chamber was visualized by confocal scanning laser microscopy (Leica TCS SP2, Germany) and then subjected to ultrasonication for determining Cy5 fluorescence with a microplate reader (Thermo Multiskan MK3, Thermo Scientific, Waltham, MA, USA). Nine male nude mice were received intrastriatal microinjections of 10 U of human recombinant IL-1β (Sigma St. Louis, MO, USA) to produce brain inflammation10 and divided into three groups, followed by intraperitoneal administration of the TFF3-Cy7 solution, PL-TFF3-Cy7 and cRGDL-TFF3-Cy7 suspensions (equivalent to 50μg/mlTFF3-Cy7). Fluorescent scans were performed 1, 3, 6, and 12 h after administration of liposomes using an in vivo image system (Caliper IVIS Spectrum, Caliper Life Science, Hopkinton, MA USA).

    • Inhibition of monocyte adhesion to brain-derived endothelial cells by dual functional RNA chimeras

      2014, Molecular Therapy Nucleic Acids
      Citation Excerpt :

      It has been proven that leukocytes play a key role in neuronal injury after cerebral ischemia reperfusion.1 These cells are rapidly recruited to the injury site after microvascular reperfusion1,2 and exert detrimental effects like increasing the blood–brain barrier (BBB) permeability3 and inducing cytotoxicity.4,5 These detrimental effects require adherence of leukocytes to the vascular endothelium first after vascular injury.1

    View all citing articles on Scopus
    View full text